Transplantation Proceedings
Volume 32, Issue 1, Supplement 1 , Pages 6-8 , February 2000

Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients

  • C Keunecke

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
  • ,
  • U Rothenpieler

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
  • ,
  • B Zanker

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
  • ,
  • H Schneeberger

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
  • ,
  • W.-D Illner

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
  • ,
  • J Theodorakis

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
  • ,
  • M Stangl

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
  • ,
  • W Land

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany
    • Corresponding Author InformationAddress reprint requests to Prof. Dr Walter Land, Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), Ludwig-Maximilians-University of Munich, Marchioninistr. 15, D-81377 Munich, Germany

References 

  1. Zanker B, Schneeberger H, Rothenpieler U. Transplantation. 1998;66,1:44
  2. Land W. Transplant Proc. 1998;30:1580
  3. Weir MR, Anderson L, Fink JC, et al.  Transplantation. 1997;64:1706
  4. Van Gelder T, Klaasen RJL, van Riemsdijk-van Overbeeke IC, et al.  Transplantation. 1997;63:1530
  5. Fritsche L, Sperschneider H, Budde K, et al.  Transplant Proc. 1998;30:1190
  6. Wombolt DG, McCune TR, Stewart M. Transplant Proc. 1998;30:1194
  7. Grinyo JM, Gil-Vernet S, Seron D, et al: Abstract 164, Int Congress on Immunosuppression, Orlando, 1997
  8. Grinyo JM for the Daclizumab/MMF Combination Renal Transplant Study Group: Abstract 202, XVII World Congress of the Transplantation Society, Montreal, 1998
  9. van Gelder T, de Kuiper R, van Besouw N, et al: Abstract 1611, XVII World Congress of the Transplantation Society, Montreal, 1998
  10. Houde I, Noel R, de Cotret R, et al: Abstract 1722, XVII World Congress of the Transplantation Society, Montreal, 1998

PII: S0041-1345(00)00808-3

Transplantation Proceedings
Volume 32, Issue 1, Supplement 1 , Pages 6-8 , February 2000